Archives of Physical Medicine and Rehabilitation
Volume 90, Issue 7 , Pages 1147-1151, July 2009

Analgesic Prescribing for Musculoskeletal Complaints in the Ambulatory Care Setting After the Introduction and Withdrawal of Cyclooxygenase-2 Inhibitors

Presented to the Association of Academic Physiatrists, February 2009, Colorado Springs, CO.

  • Richard D. Wilson, MD

      Affiliations

    • Corresponding Author InformationCorrespondence to Richard D. Wilson, MD, 2500 MetroHealth Dr, R-230, Cleveland, OH 44109

MetroHealth Rehabilitation Institute of Ohio, Center for Healthcare Research and Policy, MetroHealth Medical Center/Case Western Reserve University, Cleveland, OH

Abstract 

Wilson RD. Analgesic prescribing for musculoskeletal complaints in the ambulatory care setting after the introduction and withdrawal of cyclooxygenase-2 inhibitors.

Objective

To evaluate the analgesic prescribing patterns for musculoskeletal complaints in a nationally representative sample of ambulatory care visits over a dynamic period of pharmaceutical treatments.

Design

Sequential cross-sectional analysis of complex probabilistic survey data with multivariable logistic regression analysis.

Setting

National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey 1999 to 2005.

Participants

Visits to ambulatory care physicians in the United States from 1999 to 2005 with the reason for visit being a musculoskeletal complaint.

Interventions

Not applicable.

Main Outcome Measures

Prescribing of cyclooxygenase-2 (COX-2) inhibitors, nonselective nonsteroidal anti-inflammatory drugs (nsNSAIDs), opiate analgesics, nonnarcotic analgesics, and adjuvant analgesic medications for visits related to musculoskeletal complaints.

Results

There were 41,804 visits for musculoskeletal complaints, representing 789 million visits from 1999 to 2005 in the weighted analyses. Prescribing for any nonsteroidal anti-inflammatory drugs (NSAIDs) remained relatively stable from 1999 to 2005. It appears that COX-2 inhibitors were substituted for nsNSAIDs initially. After safety concerns arose and select COX-2 inhibitors were withdrawn, there were sharp increases in prescribing of nsNSAIDs and nonnarcotic analgesics. Opiate analgesics and adjuvant analgesics increased in usage over the study period, although apparently not in substitution for NSAIDs.

Conclusions

COX-2 inhibitors may have been prescribed as substitutes for nsNSAIDs initially, but nsNSAID prescriptions returned to prior levels by 2005 as COX-2 inhibitor prescriptions declined. An increase in nonnarcotic analgesic prescribing in 2005 may have been caused by a class effect concern for NSAIDs. Prescribing of opiate analgesics and adjuvant analgesics increased over the study period, although apparently not in substitution for NSAIDs.

Key Words: Analgesics, Health care surveys, Musculoskeletal system, Prescriptions, Rehabilitation

List of Abbreviations: COX-2, cyclooxygenase-2, NAMCS, National Ambulatory Medical Care Survey, NHAMCS, National Hospital Ambulatory Medical Care Survey, NSAID, nonsteroidal anti-inflammatory drug, nsNSAID, nonselective nonsteroidal anti-inflammatory drug

 

 Supported by the Rehabilitation Medicine Scientist Training Program (grant no. K12-HD01097).

 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit on the authors or on any organization with which the authors are associated.

 Reprints are not available from the author.

PII: S0003-9993(09)00214-7

doi:10.1016/j.apmr.2009.01.017

Archives of Physical Medicine and Rehabilitation
Volume 90, Issue 7 , Pages 1147-1151, July 2009